Financial Statement

Ebix, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands, except share amounts)
  March 31,
2020		 December 31,
2019
 
ASSETS (Unaudited)  
Current assets:    
Cash and cash equivalents $61,854 $73,228
Receivables from service providers 13,423 25,607
Short-term investments 9,236 4,443
Restricted cash 24,756 35,051
Fiduciary funds - restricted 5,293 4,966
Trade accounts receivable, less allowances of $20,179 and $21,696, respectively 135,889 153,565
Other current assets 68,667 67,074
Total current assets 319,118 363,934
 
Property and equipment, net 46,831 48,421
Right-of-use assets 16,639 19,544
Goodwill 921,367 952,404
Intangibles, net 42,749 46,955
Indefinite-lived intangibles 42,055 42,055
Capitalized software development costs, net 19,536 19,183
Deferred tax asset, net 66,842 69,227
Other assets 28,473 29,896
Total assets $1,503,610 $1,591,619
     
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Current liabilities:    
Accounts payable and accrued liabilities $70,102 $84,735
Payables to service agents 8,720 12,196
Accrued payroll and related benefits 9,356 8,755
Working capital facility 2,746 28,352
Fiduciary funds - restricted 5,293 4,966
Short-term debt 1,050 1,167
Contingent liability for accrued earn-out acquisition consideration 8,111 8,621
Current portion of long term debt and financing lease obligations, net of deferred financing
costs of $734 and $575, respectively		 23,809 22,091
Contract liabilities 29,814 28,712
Lease liability 5,268 5,955
Other current liabilities 22,892 29,335
Total current liabilities 187,161 234,885
 
Revolving line of credit 438,037 438,037
Long term debt and financing lease obligations, less current portion, net of deferred financing costs of $1,392 and $1,534, respectively 248,912 254,467
Contingent liability for accrued earn-out acquisition consideration 1,405 1,474
Contract liabilities 8,649 8,541
Lease liability 11,169 13,196
Deferred tax liability, net 1,235 1,235
Other liabilities 35,326 40,339
Total liabilities 931,894 992,174
 
Commitments and Contingencies    
 
Stockholders’ equity:    
Preferred stock, $0.10 par value, 500,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019 — —
Series Y Convertible preferred stock, $0.10 par value, 350,000 shares authorized, no shares issued and outstanding at March 31, 2020 and no shares authorized, issue and outstanding at December 31, 2019 — —
Common stock, $0.10 par value, 220,000,000 shares authorized, 30,475,994 issued and outstanding, at March 31, 2020, and 30,492,044 issued and outstanding at December 31, 2019 3,048 3,049
Additional paid-in capital 8,211 6,960
Retained earnings 639,596 618,503
Accumulated other comprehensive loss (128,192 (78,398
Total Ebix, Inc. stockholders’ equity 522,663 550,114
Noncontrolling interest 49,053 49,331
Total stockholders’ equity 571,716 599,445
Total liabilities and stockholders’ equity $ 1,503,610 $ 1,591,619
Investor Home

Investor Contacts

EBIX Inc
1 Ebix Way, Johns Creek, Georgia 30097
Ph: 678-281-2027 Fax: 678-281-2019

IR@ebix.com

David Collins, Tanya Kamatu, Chris Eddy
Catalyst Global - 212-924-9800 or ebix@catalyst-ir.com

Ebix Named in Fortune’s 2017 100 Fastest-Growing Companies

Follow us

   

Ebix Inc.
1 Ebix Way, Johns Creek,
GA 30097

Tel: +1 (678) 281-2020
Fax: +1 (678) 281-2019

  • Join Us

Copyright © 2022 Ebix Inc. Terms Of Use | Privacy Statement